Selective serotonin reuptake inhibitors in the treatment of generalized anxiety disorder
- 1 September 2002
- journal article
- Published by Taylor & Francis in Expert Review of Neurotherapeutics
- Vol. 2 (5) , 717-724
- https://doi.org/10.1586/14737175.2.5.717
Abstract
Selective serotonin reuptake inhibitors have proven efficacy in the treatment of panic disorder, obsessive-compulsive disorder, post-traumatic stress disorder and social anxiety disorder. Accumulating data shows that selective serotonin reuptake inhibitor treatment can also be efficacious in patients with generalized anxiety disorder. This review summarizes the findings of randomized controlled trials of selective serotonin reuptake inhibitor treatment for generalized anxiety disorder, examines the strengths and weaknesses of other therapeutic approaches and considers potential new treatments for patients with this chronic and disabling anxiety disorder.Keywords
This publication has 24 references indexed in Scilit:
- Paroxetine in the Treatment of Generalized Anxiety DisorderThe Journal of Clinical Psychiatry, 2001
- FluoxetineCNS Drugs, 2000
- Efficacy of Extended-Release Venlafaxine in Nondepressed Outpatients With Generalized Anxiety DisorderAmerican Journal of Psychiatry, 2000
- Cognitive behavioral and pharmacological treatment of generalized anxiety disorder: A preliminary meta-analysisBehavior Therapy, 1997
- Open Fluoxetine Treatment of Mixed Anxiety Disorders in Children and AdolescentsJournal of Child and Adolescent Psychopharmacology, 1997
- Peripheral‐type benzodiazepine receptors in anxiety disordersActa Psychiatrica Scandinavica, 1991
- Controlled Comparison of Buspirone and Oxazepam in Generalized AnxietyNeuropsychobiology, 1990
- A controlled comparison of cognitive- behaviour therapy, Diazepam, and placebo, alone and in combination, for the treatment of generalised anxiety disorderJournal of Anxiety Disorders, 1990
- Cognitive therapy vs behaviour therapy in the treatment of chronic general anxietyBehaviour Research and Therapy, 1987
- BuspironeDrugs, 1986